ArriVent BioPharma, Inc. Common Stock
ArriVent BioPharma, Inc. Common Stock (AVBP) Number of Employees – History & Annual Headcount
Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.
SEC EDGAR · FMP · AVBP · as of Mar 5, 2026
Latest filing snapshot
ArriVent BioPharma, Inc. Common Stock (AVBP) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗
AVBP Employee Count
2023 – 2025 · Annual · SEC filingSource: SEC annual filings · Hover bar to view year data · Click to view original filing
Employees History
| Filing Date | Employees | Change (1Y) | Growth (1Y) | SEC filing link |
|---|---|---|---|---|
| 2026-03-05 | 77 | +25 | +48.08% | |
| 2025-03-03 | 52 | +12 | +30.00% | |
| 2024-03-28 | 40 | — | — |
▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.
Related Companies — Employee Count
Biotechnology
About AVBP employees
AVBP Employees · Headcount
ArriVent BioPharma, Inc. Common Stock (AVBP) employee data is sourced from the annual SEC 10-K filing. As of 2025, ArriVent BioPharma, Inc. Common Stock had 77 full-time employees globally. Full-time employees only. Global consolidated headcount.
ArriVent BioPharma, Inc. Common Stock's workforce increased by 25 (48.08%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.
Frequently Asked Questions
AVBP Employees · 5 questionsAs of the latest SEC 10-K filing (2025), ArriVent BioPharma, Inc. Common Stock had 77 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.
▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-05